These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 29642408)
1. Mucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India. Chander J; Kaur M; Singla N; Punia RPS; Singhal SK; Attri AK; Alastruey-Izquierdo A; Stchigel AM; Cano-Lira JF; Guarro J J Fungi (Basel); 2018 Apr; 4(2):. PubMed ID: 29642408 [TBL] [Abstract][Full Text] [Related]
2. A prospective study of mucormycosis in north India: experience from a tertiary care hospital. Bala K; Chander J; Handa U; Punia RS; Attri AK Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Chowdhary A; Kathuria S; Singh PK; Sharma B; Dolatabadi S; Hagen F; Meis JF Mycoses; 2014 Dec; 57 Suppl 3():97-107. PubMed ID: 25250768 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Mucormycosis in India. Prakash H; Chakrabarti A Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33806386 [TBL] [Abstract][Full Text] [Related]
5. Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy. Gupta S; Goyal R; Kaore NM Indian J Otolaryngol Head Neck Surg; 2020 Mar; 72(1):104-111. PubMed ID: 32158665 [TBL] [Abstract][Full Text] [Related]
6. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India. Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616 [TBL] [Abstract][Full Text] [Related]
14. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895 [TBL] [Abstract][Full Text] [Related]
15. Saksenaea erythrospora, an emerging mucoralean fungus causing severe necrotizing skin and soft tissue infections - a study from a tertiary care hospital in north India Chander J; Singla N; Kaur M; Punia RS; Attri A; Alastruey-Izquierdo A; Cano-Lira JF; Stchigel AM; Guarro J Infect Dis (Lond); 2017 Mar; 49(3):170-177. PubMed ID: 27701965 [TBL] [Abstract][Full Text] [Related]
16. A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment. Prakash H; Ghosh AK; Rudramurthy SM; Singh P; Xess I; Savio J; Pamidimukkala U; Jillwin J; Varma S; Das A; Panda NK; Singh S; Bal A; Chakrabarti A Med Mycol; 2019 Jun; 57(4):395-402. PubMed ID: 30085158 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 and Mucormycosis: A Black Fungus Disaster? Chillana S; Mohit Chilana KA Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825 [TBL] [Abstract][Full Text] [Related]
18. Rhizopus homothallicus rhino-orbital-cerebral mucormycosis: Six cases from a tertiary care Centre, North India. Gupta MK; Selvaraj S; Tilak R; Kumar N; Kumar R; Chakravarty J Trop Med Int Health; 2023 Feb; 28(2):144-150. PubMed ID: 36517958 [TBL] [Abstract][Full Text] [Related]
19. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa. Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276 [TBL] [Abstract][Full Text] [Related]
20. The environmental source of emerging Apophysomyces variabilis infection in India. Prakash H; Ghosh AK; Rudramurthy SM; Paul RA; Gupta S; Negi V; Chakrabarti A Med Mycol; 2016 Aug; 54(6):567-75. PubMed ID: 27118802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]